D2L Inc. (TSX: DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced that the Toronto ...

D2L Inc. ( DTOL:CA) Q3 2026 Earnings Call December 11, 2025 9:00 AM EST Good morning, and thank you for attending the D2L Inc ...

D2L Inc. (TSX: DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced financial results for its Fiscal 2026 third quarter ended October 31, 2025. All amounts are ...

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, inflammatory and ...

Beren Therapeutics P.B.C.®, a Public Benefit Corporation and parent company of Mandos LLC®, today announced that Mandos received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug ...

TORONTO, Dec. 9, 2025 /CNW/ – D2L Inc. (TSX: DTOL) (“D2L” or the “Company”), a leading global learning technology company, today announced that the Toronto Stock Exchange (the “TSX”) has accepted the ...

When the lights snapped off across Arapahoe Community College’s Littleton (ACC) campus, the blustery morning of October 20, ...

D2L Inc. reported its third-quarter earnings for 2025, showing flat revenue growth year-over-year, with total revenue at CAD 54.1 million. The company’s stock fell by 11.83% following the earnings ...

Management uses a number of metrics, including the key performance indicators identified below, to help us evaluate our business, measure our performance, identify trends affecting our business, ...